ad image

Censa Pharmaceuticals

1 / 1
PTC Therapeutics, Inc.
M&A

PTC Therapeutics to Acquire Censa Pharmaceuticals

PTC Therapeutics, Inc.

PR-M05-20-NI-011May 07, 2020
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
Drug Development

A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways

Jonathan Reis, Ph.D.

PAP-Q1-20-CL-011Mar 19, 2020
1 / 1